The Effect of Testosterone on Cardiovascular Disease: A Critical Review of the Literature

American Journal of Men's Health

Volumn 8, Issue 6, 2014, Pages 470-491

  Su, Jeannie J ^a   Park, Samuel K ^a   Hsieh, T Mike ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

cardiovascular disease; hypogonadism; testosterone

Indexed keywords

TESTOSTERONE;

ADULT; AGED; CARDIOVASCULAR DISEASES; COMPLICATION; DEFICIENCY; FOLLOW UP; HORMONE SUBSTITUTION; HUMAN; HYPOGONADISM; MALE; MEN'S HEALTH; MIDDLE AGED; PATHOPHYSIOLOGY; PROCEDURES; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK ASSESSMENT; TREATMENT OUTCOME;

ADULT; AGED; CARDIOVASCULAR DISEASES; FOLLOW-UP STUDIES; HORMONE REPLACEMENT THERAPY; HUMANS; HYPOGONADISM; MALE; MEN'S HEALTH; MIDDLE AGED; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK ASSESSMENT; TESTOSTERONE; TREATMENT OUTCOME;

EID: 84912014028     PISSN: 15579883     EISSN: 15579891     Source Type: Journal    
DOI: 10.1177/1557988314522642     Document Type: Article

References (153)

1. Abbott R. D.,Launer L. J.,Rodriguez B. L.,Ross G. W.,Wilson P. W.,Masaki K. H.,.. Petrovitch H.Serum estradiol and risk of stroke in elderly men.Neurology. 2007;68:563-568
2. Ajayi A. A.,Halushka P. V.Castration reduces platelet thromboxane A2 receptor density and aggregability.QJM: Monthly Journal of the Association of Physicians. 2005;98:349-356
3. Andresdottir M. B.,Sigurdsson G.,Sigvaldason H.,Gudnason V.Fifteen percent of myocardial infarctions and coronary revascularizations explained by family history unrelated to conventional risk factors. The Reykjavik Cohort Study.European Heart Journal. 2002;23:1655-1663
4. Arnlov J.,Pencina M. J.,Amin S.,Nam B. H.,Benjamin E. J.,Murabito J. M.,.. Vasan R. S.Endogenous sex hormones and cardiovascular disease incidence in men.Annals of Internal Medicine. 2006;145:176-184
5. Aversa A.,Bruzziches R.,Francomano D.,Rosano G.,Isidori A. M.,Lenzi A.,Spera G.Effects of testosterone undecanoate on cardiovascular risk factors and atherosclerosis in middle-aged men with late-onset hypogonadism and metabolic syndrome: Results from a 24-month, randomized, double-blind, placebo-controlled study.Journal of Sexual Medicine. 2010;7:3495-3503
6. Bachman E.,Feng R.,Travison T.,Li M.,Olbina G.,Ostland V.,.. Bhasin S.Testosterone suppresses hepcidin in men: A potential mechanism for testosterone-induced erythrocytosis.Journal of Clinical Endocrinology & Metabolism. 2010;95:4743-4747
7. Bachman E.,Travison T. G.,Basaria S.,Davda M. N.,Guo W.,Li M.,.. Bhasin S.Testosterone induces erythrocytosis via increased erythropoietin and suppressed hepcidin: Evidence for a new erythropoietin/hemoglobin set point.Journals of Gerontology. Series A, Biological Sciences and Medical Sciences. 2013;:
8. Barrett-Connor E.,Khaw K. T.Endogenous sex hormones and cardiovascular disease in men. A prospective population-based study.Circulation. 1988;78:539-545
9. Basaria S.,Coviello A. D.,Travison T. G.,Storer T. W.,Farwell W. R.,Jette A. M.,.. Bhasin S.Adverse events associated with testosterone administration.New England Journal of Medicine. 2010;363:109-122
10. Bhasin S.,Storer T. W.,Berman N.,Callegari C.,Clevenger B.,Phillips J.,.. Casaburi R.The effects of supraphysiologic doses of testosterone on muscle size and strength in normal men.New England Journal of Medicine. 1996;335:1-7
11. Bobjer J.,Katrinaki M.,Tsatsanis C.,Giwercman Y. L.,Giwercman A.Negative association between testosterone concentration and inflammatory markers in young men: A nested cross-sectional study.PLoS One. 2013;8 (4): e61466
12. Bocchi E. A.,Carvalho V. O.,Guimaraes G. V.Inverse correlation between testosterone and ventricle ejection fraction, hemodynamics and exercise capacity in heart failure patients with erectile dysfunction.International Brazilian Journal of Urology. 2008;34:302-310
13. Breier C.,Muhlberger V.,Drexel H.,Herold M.,Lisch H. J.,Knapp E.,Braunsteiner H.Essential role of post-heparin lipoprotein lipase activity and of plasma testosterone in coronary artery disease.Lancet. 1985;1 (8440): 1242-1244
14. Calderon-Margalit R.,Schwartz S. M.,Wellons M. F.,Lewis C. E.,Daviglus M. L.,Schreiner P. J.,.. Siscovick D. S.Prospective association of serum androgens and sex hormone-binding globulin with subclinical cardiovascular disease in young adult women: The “Coronary Artery Risk Development in Young Adults” women’s study.Journal of Clinical Endocrinology & Metabolism. 2010;95:4424-4431
15. Calof O. M.,Singh A. B.,Lee M. L.,Kenny A. M.,Urban R. J.,Tenover J. L.,Bhasin S.Adverse events associated with testosterone replacement in middle-aged and older men: A meta-analysis of randomized, placebo-controlled trials.Journals of Gerontology. Series A, Biological Sciences and Medical Sciences. 2005;60:1451-1457
16. Caminiti G.,Volterrani M.,Iellamo F.,Marazzi G.,Massaro R.,Miceli M.,.. Rosano G. M.Effect of long-acting testosterone treatment on functional exercise capacity, skeletal muscle performance, insulin resistance, and baroreflex sensitivity in elderly patients with chronic heart failure: A double-blind, placebo-controlled, randomized study.Journal of the American College of Cardiology. 2009;54:919-927
17. Cao J.,Zou H.,Zhu B. P.,Wang H.,Li J.,Ding Y.,Li X. Y.Sex hormones and androgen receptor: Risk factors of coronary heart disease in elderly men.Chinese Medical Sciences Journal. 2010;25:44-49
18. Chrysohoou C.,Panagiotakos D.,Pitsavos C.,Siasos G.,Oikonomou E.,Varlas J.,.. Stefanadis C.Low total testosterone levels are associated with the metabolic syndrome in elderly men: The role of body weight, lipids, insulin resistance, and inflammation; the Ikaria study.Review of Diabetic Studies. 2013;10:27-38
19. Chute C. G.,Baron J. A.,Plymate S. R.,Kiel D. P.,Pavia A. T.,Lozner E. C.,.. MacDonald G. J.Sex hormones and coronary artery disease.American Journal of Medicine. 1987;83:853-859
20. Colangelo L. A.,Ouyang P.,Liu K.,Kopp P.,Golden S. H.,Dobs A. S.,.. Gapstur S. M.Association of endogenous sex hormones with diabetes and impaired fasting glucose in men: Multi-ethnic study of atherosclerosis.Diabetes Care. 2009;32:1049-1051
21. Contoreggi C. S.,Blackman M. R.,Andres R.,Muller D. C.,Lakatta E. G.,Fleg J. L.,Harman S. M.Plasma levels of estradiol, testosterone, and DHEAS do not predict risk of coronary artery disease in men.Journal of Andrology. 1990;11:460-470
22. Corcoran M. P.,Meydani M.,Lichtenstein A. H.,Schaefer E. J.,Dillard A.,Lamon-Fava S.Sex hormone modulation of proinflammatory cytokine and C-reactive protein expression in macrophages from older men and postmenopausal women.Journal of Endocrinology. 2010;206:217-224
23. Cornoldi A.,Caminiti G.,Marazzi G.,Vitale C.,Patrizi R.,Volterrani M.,.. Rosano G.Effects of chronic testosterone administration on myocardial ischemia, lipid metabolism and insulin resistance in elderly male diabetic patients with coronary artery disease.International Journal of Cardiology. 2010;142:50-55
24. Corona G.,Mannucci E.,Lotti F.,Fisher A. D.,Bandini E.,Balercia G.,.. Maggi M.Pulse pressure, an index of arterial stiffness, is associated with androgen deficiency and impaired penile blood flow in men with ED.Journal of Sexual Medicine. 2009;6:285-293
25. Corona G.,Monami M.,Rastrelli G.,Aversa A.,Tishova Y.,Saad F.,.. Maggi M.Testosterone and metabolic syndrome: A meta-analysis study.Journal of Sexual Medicine. 2011;8:272-283
26. Corona G.,Rastrelli G.,Vignozzi L.,Mannucci E.,Maggi M.Testosterone, cardiovascular disease and the metabolic syndrome.Best Practice & Research. Clinical Endocrinology & Metabolism. 2011;25:337-353
27. Coviello A. D.,Kaplan B.,Lakshman K. M.,Chen T.,Singh A. B.,Bhasin S.Effects of graded doses of testosterone on erythropoiesis in healthy young and older men.Journal of Clinical Endocrinology & Metabolism. 2008;93:914-919
28. D’Andrea A.,Caso P.,Salerno G.,Scarafile R.,De Corato G.,Mita C.,.. Calabro R.Left ventricular early myocardial dysfunction after chronic misuse of anabolic androgenic steroids: A Doppler myocardial and strain imaging analysis.British Journal of Sports Medicine. 2007;41:149-155
29. Danesh J.,Lewington S.,Thompson S. G.,Lowe G. D.,Collins R.,Kostis J. B.,.. Wood A.Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: An individual participant meta-analysis.Journal of the American Medical Association. 2005;294:1799-1809
30. Davoodi G.,Amirezadegan A.,Borumand M. A.,Dehkori M. R.,Kazemisaeid A.,Yaminisharif A.The relationship between level of androgenic hormones and coronary artery disease in men.Cardiovascular Journal of Africa. 2007;18:362-366
31. Debing E.,Peeters E.,Duquet W.,Poppe K.,Velkeniers B.,Van Den Brande P.Men with atherosclerotic stenosis of the carotid artery have lower testosterone levels compared with controls.International Angiology. 2008;27:135-141
32. De Pergola G.,Pannacciulli N.,Ciccone M.,Tartagni M.,Rizzon P.,Giorgino R.Free testosterone plasma levels are negatively associated with the intima-media thickness of the common carotid artery in overweight and obese glucose-tolerant young adult men.International Journal of Obesity and Related Metabolic Disorders. 2003;27:803-807
33. Dockery F.,Bulpitt C. J.,Donaldson M.,Fernandez S.,Rajkumar C.The relationship between androgens and arterial stiffness in older men.Journal of the American Geriatrics Society. 2003;51:1627-1632
34. Duell P. B.,Bierman E. L.The relationship between sex hormones and high-density lipoprotein cholesterol levels in healthy adult men.Archives of Internal Medicine. 1990;150:2317-2320
35. El Khoudary S. R.,Wildman R. P.,Matthews K.,Thurston R. C.,Bromberger J. T.,Sutton-Tyrrell K.Endogenous sex hormones impact the progression of subclinical atherosclerosis in women during the menopausal transition.Atherosclerosis. 2012;225:180-186
36. English K. M.,Steeds R. P.,Jones T. H.,Diver M. J.,Channer K. S.Low-dose transdermal testosterone therapy improves angina threshold in men with chronic stable angina: A randomized, double-blind, placebo-controlled study.Circulation. 2000;102:1906-1911
37. Fernandez-Balsells M. M.,Murad M. H.,Lane M.,Lampropulos J. F.,Albuquerque F.,Mullan R. J.,.. Montori V. M.Clinical review 1: Adverse effects of testosterone therapy in adult men: a systematic review and meta-analysis.Journal of Clinical Endocrinology & Metabolism. 2010;95:2560-2575
38. Florvaag A.,Oberle V.,Fritzenwanger M.,Kretschmar D.,Betge S.,Goebel B.,.. Jung C.Testosterone deficiency in male heart failure patients and its effect on endothelial progenitor cells.The Aging Male. 2012;15:180-186
39. Foresta C.,De Toni L.,Selice R.,Garolla A.,Di Mambro A.Increased osteocalcin-positive endothelial progenitor cells in hypogonadal male patients.Journal of Endocrinological Investigation. 2010;33:439-442
40. Fu L.,Gao Q. P.,Shen J. X.Relationship between testosterone and indexes indicating endothelial function in male coronary heart disease patients.Asian Journal of Andrology. 2008;10:214-218
41. Fukui M.,Kitagawa Y.,Nakamura N.,Kadono M.,Mogami S.,Hirata C.,.. Yoshikawa T.Association between serum testosterone concentration and carotid atherosclerosis in men with type 2 diabetes.Diabetes Care. 2003;26:1869-1873
42. Fukui M.,Ose H.,Kitagawa Y.,Yamazaki M.,Hasegawa G.,Yoshikawa T.,Nakamura N.Relationship between low serum endogenous androgen concentrations and arterial stiffness in men with type 2 diabetes mellitus.Metabolism. 2007;56:1167-1173
43. Fullerton H. J.,Wu Y. W.,Sidney S.,Johnston S. C.Risk of recurrent childhood arterial ischemic stroke in a population-based cohort: The importance of cerebrovascular imaging.Pediatrics. 2007;119:495-501
44. Golomb M. R.,Dick P. T.,MacGregor D. L.,Curtis R.,Sofronas M.,deVeber G. A.Neonatal arterial ischemic stroke and cerebral sinovenous thrombosis are more commonly diagnosed in boys.Journal of Child Neurology. 2004;19:493-497
45. Golomb M. R.,Fullerton H. J.,Nowak-Gottl U.,Deveber G.Male predominance in childhood ischemic stroke: Findings from the international pediatric stroke study.Stroke. 2009;40:52-57
46. Guder G.,Frantz S.,Bauersachs J.,Allolio B.,Ertl G.,Angermann C. E.,Stork S.Low circulating androgens and mortality risk in heart failure.Heart. 2010;96:504-509
47. Guler N.,Batyraliev T.,Dulger H.,Ozkara C.,Tuncer M.,Aslan S.,.. Agirbasli M.The effects of short term (3 weeks) testosterone treatment on serum inflammatory markers in men undergoing coronary artery stenting.International Journal of Cardiology. 2006;109:339-343
48. Haas M. J.,Raheja P.,Jaimungal S.,Sheikh-Ali M.,Mooradian A. D.Estrogen-dependent inhibition of dextrose-induced endoplasmic reticulum stress and superoxide generation in endothelial cells.Free Radical Biology & Medicine. 2012;52:2161-2167
49. Haring R.,Teng Z.,Xanthakis V.,Coviello A.,Sullivan L.,Bhasin S.,.. Vasan R. S.Association of sex steroids, gonadotrophins, and their trajectories with clinical cardiovascular disease and all-cause mortality in elderly men from the Framingham Heart Study.Clinical Endocrinology. 2013;78:629-634
50. Haring R.,Travison T. G.,Bhasin S.,Vasan R. S.,Wallaschofski H.,Davda M. N.,.. Murabito J. M.Relation between sex hormone concentrations, peripheral arterial disease, and change in ankle-brachial index: findings from the Framingham Heart Study.Journal of Clinical Endocrinology & Metabolism. 2011;96:3724-3732
51. Harman S. M.,Metter E. J.,Tobin J. D.,Pearson J.,Blackman M. R.Longitudinal effects of aging on serum total and free testosterone levels in healthy men. Baltimore Longitudinal Study of Aging.Journal of Clinical Endocrinology & Metabolism. 2001;86:724-731
52. Heller R. F.,Miller N. E.,Wheeler M. J.,Kind P. R.Coronary heart disease in “low risk” men.Atherosclerosis. 1983;49:187-193
53. Hernandez-Mijares A.,Garcia-Malpartida K.,Sola-Izquierdo E.,Banuls C.,Rocha M.,Gomez-Martinez M. J.,.. Victor V. M.Testosterone levels in males with type 2 diabetes and their relationship with cardiovascular risk factors and cardiovascular disease.Journal of Sexual Medicine. 2010;7:1954-1964
54. Hu X.,Rui L.,Zhu T.,Xia H.,Yang X.,Wang X.,.. Jiang H.Low testosterone level in middle-aged male patients with coronary artery disease.European Journal of Internal Medicine. 2011;22:e133-136
55. Iellamo F.,Volterrani M.,Caminiti G.,Karam R.,Massaro R.,Fini M.,.. Rosano G. M.Testosterone therapy in women with chronic heart failure: A pilot double-blind, randomized, placebo-controlled study.Journal of the American College of Cardiology. 2010;56:1310-1316
56. Izquierdo M.,Hakkinen K.,Anton A.,Garrues M.,Ibanez J.,Ruesta M.,Gorostiaga E. M.Maximal strength and power, endurance performance, and serum hormones in middle-aged and elderly men.Medicine & Science in Sports & Exercise. 2001;33:1577-1587
57. Jaffe M. D.Effect of testosterone cypionate on postexercise ST segment depression.British Heart Journal. 1977;39:1217-1222
58. Jankowska E. A.,Biel B.,Majda J.,Szklarska A.,Lopuszanska M.,Medras M.,.. Ponikowski P.Anabolic deficiency in men with chronic heart failure: Prevalence and detrimental impact on survival.Circulation. 2006;114:1829-1837
59. Jankowska E. A.,Filippatos G.,Ponikowska B.,Borodulin-Nadzieja L.,Anker S. D.,Banasiak W.,.. Ponikowski P.Reduction in circulating testosterone relates to exercise capacity in men with chronic heart failure.Journal of Cardiac Failure. 2009;15:442-450
60. Johannsson G.,Gibney J.,Wolthers T.,Leung K. C.,Ho K. K.Independent and combined effects of testosterone and growth hormone on extracellular water in hypopituitary men.Journal of Clinical Endocrinology & Metabolism. 2005;90:3989-3994
61. Kaczmarek A.,Reczuch K.,Majda J.,Banasiak W.,Ponikowski P.The association of lower testosterone level with coronary artery disease in postmenopausal women.International Journal of Cardiology. 2003;87:53-57
62. Kajinami K.,Takeda K.,Takekoshi N.,Matsui S.,Tsugawa H.,Kanemitsu S.,.. Fukuda A.Imbalance of sex hormone levels in men with coronary artery disease.Coronary Artery Disease. 2004;15:199-203
63. Kalinchenko S.,Zemlyanoy A.,Gooren L. J.Improvement of the diabetic foot upon testosterone administration to hypogonadal men with peripheral arterial disease. Report of three cases.Cardiovascular Diabetology. 2009;8:19
64. Kang S. M.,Jang Y.,Kim J.,Chung N.,Cho S. Y.,Chae J. S.,Lee J. H.Effect of oral administration of testosterone on brachial arterial vasoreactivity in men with coronary artery disease.American Journal of Cardiology. 2002;89:862-864
65. Kappert K.,Bohm M.,Schmieder R.,Schumacher H.,Teo K.,Yusuf S.,.. Unger T.Impact of sex on cardiovascular outcome in patients at high cardiovascular risk: Analysis of the Telmisartan Randomized Assessment Study in ACE-Intolerant Subjects With Cardiovascular Disease (TRANSCEND) and the Ongoing Telmisartan Alone and in Combination With Ramipril Global End Point Trial (ONTARGET).Circulation. 2012;126:934-941
66. Kaptoge S.,White I. R.,Thompson S. G.,Wood A. M.,Lewington S.,Lowe G. D.,Danesh J.Associations of plasma fibrinogen levels with established cardiovascular disease risk factors, inflammatory markers, and other characteristics: Individual participant meta-analysis of 154,211 adults in 31 prospective studies: The fibrinogen studies collaboration.American Journal of Epidemiology. 2007;166:867-879
67. Karila T. A.,Karjalainen J. E.,Mantysaari M. J.,Viitasalo M. T.,Seppala T. A.Anabolic androgenic steroids produce dose-dependant increase in left ventricular mass in power atheletes, and this effect is potentiated by concomitant use of growth hormone.International Journal of Sports Medicine. 2003;24:337-343
68. Khaw K. T.,Barrett-Connor E.Lower endogenous androgens predict central adiposity in men.Annals of Epidemiology. 1992;2:675-682
69. Kontoleon P. E.,Anastasiou-Nana M. I.,Papapetrou P. D.,Alexopoulos G.,Ktenas V.,Rapti A. C.,.. Nanas J. N.Hormonal profile in patients with congestive heart failure.International Journal of Cardiology. 2003;87:179-183
70. Kupelian V.,Hayes F. J.,Link C. L.,Rosen R.,McKinlay J. B.Inverse association of testosterone and the metabolic syndrome in men is consistent across race and ethnic groups.Journal of Clininical Endocrinology & Metabolism. 2008;93:3403-3410
71. Kyriazis J.,Tzanakis I.,Stylianou K.,Katsipi I.,Moisiadis D.,Papadaki A.,.. Daphnis E.Low serum testosterone, arterial stiffness and mortality in male haemodialysis patients.Nephrology, Dialysis, Transplantation. 2011;26:2971-2977
72. Laaksonen D. E.,Niskanen L.,Punnonen K.,Nyyssonen K.,Tuomainen T. P.,Valkonen V. P.,.. Salonen J. T.Testosterone and sex hormone-binding globulin predict the metabolic syndrome and diabetes in middle-aged men.Diabetes Care. 2004;27:1036-1041
73. Laslett L. J.,Alagona P.,Clark B. A.,Drozda J. P.,Saldivar F.,Wilson S. R.,.. Hart M.The worldwide environment of cardiovascular disease: Prevalence, diagnosis, therapy, and policy issues: A report from the American College of Cardiology.Journal of the American College of Cardiology, 60. 2012;:S1-49
74. Laurent S.,Tropeano A. I.,Boutouyrie P.Pulse pressure reduction and cardiovascular protection.Journal of Hypertension. 2006;24:S13-18
75. Li C.,Ford E. S.,Li B.,Giles W. H.,Liu S.Association of testosterone and sex hormone-binding globulin with metabolic syndrome and insulin resistance in men.Diabetes Care. 2010;33:1618-1624
76. Li L.,Guo C. Y.,Jia E. Z.,Zhu T. B.,Wang L. S.,Cao K. J.,.. Yang Z. J.Testosterone is negatively associated with the severity of coronary atherosclerosis in men.Asian Journal of Andrology. 2012;14:875-878
77. Libby P.,Ridker P. M.,Maseri A.Inflammation and atherosclerosis.Circulation. 2002;105:1135-1143
78. Lichtenstein M. J.,Yarnell J. W.,Elwood P. C.,Beswick A. D.,Sweetnam P. M.,Marks V.,.. Riad-Fahmy D.Sex hormones, insulin, lipids, and prevalent ischemic heart disease.American Journal of Epidemiology. 1987;126:647-657
79. Lloyd-Jones D. M.,Larson M. G.,Beiser A.,Levy D.Lifetime risk of developing coronary heart disease.Lancet. 1999;353:89-92
80. Lloyd-Jones D. M.,Nam B. H.,D’Agostino R. B.,Levy D.,Murabito J. M.,Wang T. J.,.. O’Donnell C. J.Parental cardiovascular disease as a risk factor for cardiovascular disease in middle-aged adults: A prospective study of parents and offspring.Journal of the American Medical Association. 2004;291:2204-2211
81. Luria M. H.,Johnson M. W.,Pego R.,Seuc C. A.,Manubens S. J.,Wieland M. R.,Wieland R. G.Relationship between sex hormones, myocardial infarction, and occlusive coronary disease.Archives of Internal Medicine. 1982;142:42-44
82. Maggio M.,Cattabiani C.,Lauretani F.,Artoni A.,Bandinelli S.,Schiavi G.,.. Ceda G. P.The relationship between sex hormones, sex hormone binding globulin and peripheral artery disease in older persons.Atherosclerosis. 2012;225:469-474
83. Maggio M.,Snyder P. J.,Ceda G. P.,Milaneschi Y.,Luci M.,Cattabiani C.,.. Ferrucci L.Is the haematopoietic effect of testosterone mediated by erythropoietin? The results of a clinical trial in older men.Andrology. 2013;1:24-28
84. Malkin C. J.,Jones T. H.,Channer K. S.The effect of testosterone on insulin sensitivity in men with heart failure.European Journal of Heart Failure. 2007;9:44-50
85. Malkin C. J.,Pugh P. J.,Jones R. D.,Jones T. H.,Channer K. S.Testosterone as a protective factor against atherosclerosis–immunomodulation and influence upon plaque development and stability.The Journal of Endocrinology. 2003;178 (3): 373-380
86. Malkin C. J.,Pugh P. J.,Jones R. D.,Kapoor D.,Channer K. S.,Jones T. H.The effect of testosterone replacement on endogenous inflammatory cytokines and lipid profiles in hypogonadal men.Journal of Clinical Endocrinology & Metabolism. 2004;89:3313-3318
87. Malkin C. J.,Pugh P. J.,Morris P. D.,Asif S.,Jones T. H.,Channer K. S.Low serum testosterone and increased mortality in men with coronary heart disease.Heart. 2010;96:1821-1825
88. Malkin C. J.,Pugh P. J.,Morris P. D.,Kerry K. E.,Jones R. D.,Jones T. H.,Channer K. S.Testosterone replacement in hypogonadal men with angina improves ischaemic threshold and quality of life.Heart. 2004;90:871-876
89. Malkin C. J.,Pugh P. J.,West J. N.,van Beek E. J.,Jones T. H.,Channer K. S.Testosterone therapy in men with moderate severity heart failure: A double-blind randomized placebo controlled trial.European Heart Journal. 2006;27:57-64
90. Mathur A.,Malkin C.,Saeed B.,Muthusamy R.,Jones T. H.,Channer K.Long-term benefits of testosterone replacement therapy on angina threshold and atheroma in men.European Journal of Endocrinology. 2009;161:443-449
91. Mikulec K. H.,Holloway L.,Krasnow R. E.,Javitz H.,Swan G. E.,Reed T.,.. Carmelli D.Relationship of endogenous sex hormones to coronary heart disease: A twin study.Journal of Clinical Endocrinology & Metabolism. 2004;89:1240-1245
92. Montalcini T.,Gorgone G.,Gazzaruso C.,Sesti G.,Perticone F.,Pujia A.Endogenous testosterone and endothelial function in postmenopausal women.Coronary Artery Disease. 2007;18:9-13
93. Muller M.,Grobbee D. E.,den Tonkelaar I.,Lamberts S. W.,van der Schouw Y. T.Endogenous sex hormones and metabolic syndrome in aging men.Journal of Clinical Endocrinology & Metabolism. 2005;90:2618-2623
94. Nheu L.,Nazareth L.,Xu G. Y.,Xiao F. Y.,Luo R. Z.,Komesaroff P.,Ling S.Physiological effects of androgens on human vascular endothelial and smooth muscle cells in culture.Steroids. 2011;76:1590-1596
95. Normann S.,de Veber G.,Fobker M.,Langer C.,Kenet G.,Bernard T. J.,.. Nowak-Gottl U.Role of endogenous testosterone concentration in pediatric stroke.Annals of Neurology. 2009;66:754-758
96. Ong P. J.,Patrizi G.,Chong W. C.,Webb C. M.,Hayward C. S.,Collins P.Testosterone enhances flow-mediated brachial artery reactivity in men with coronary artery disease.American Journal of Cardiology. 2000;85:269-272
97. Page S. T.,Amory J. K.,Bowman F. D.,Anawalt B. D.,Matsumoto A. M.,Bremner W. J.,Tenover J. L.Exogenous testosterone (T) alone or with finasteride increases physical performance, grip strength, and lean body mass in older men with low serum T.Journal of Clinical Endocrinology & Metabolism. 2005;90:1502-1510
98. Pearson L. J.,Yandle T. G.,Nicholls M. G.,Evans J. J.Regulation of endothelin-1 release from human endothelial cells by sex steroids and angiotensin-II.Peptides. 2008;29:1057-1061
99. Phillips G. B.,Pinkernell B. H.,Jing T. Y.The association of hypotestosteronemia with coronary artery disease in men.Arteriosclerosis and Thrombosis. 1994;14:701-706
100. Ponholzer A.,Madersbacher S.,Rauchenwald M.,Jungwirth S.,Fischer P.,Tragl K. H.Vascular risk factors and their association to serum androgen levels in a population-based cohort of 75-year-old men over 5 years: Results of the VITA study.World Journal of Urology. 2010;28:209-214
101. Ponikowska B.,Jankowska E. A.,Maj J.,Wegrzynowska-Teodorczyk K.,Biel B.,Reczuch K.,.. Ponikowski P.Gonadal and adrenal androgen deficiencies as independent predictors of increased cardiovascular mortality in men with type II diabetes mellitus and stable coronary artery disease.International Journal of Cardiology. 2010;143:343-348
102. Price J.,Leng G. C.Steroid sex hormones for lower limb atherosclerosis.Cochrane Database of Systematic Reviews. 2012;10:
103. Pugh P. J.,Channer K. S.,Parry H.,Downes T.,Jone T. H.Bio-available testosterone levels fall acutely following myocardial infarction in men: Association with fibrinolytic factors.Endocrine Research. 2002;28:161-173
104. Pugh P. J.,Jones R. D.,Malkin C. J.,Hall J.,Nettleship J. E.,Kerry K. E.,.. Channer K. S.Physiologic testosterone therapy has no effect on serum levels of tumour necrosis factor-alpha in men with chronic heart failure.Endocrine Research. 2005;31:271-283
105. Pugh P. J.,Jones R. D.,West J. N.,Jones T. H.,Channer K. S.Testosterone treatment for men with chronic heart failure.Heart. 2004;90:446-447
106. Quan A.,Chakravarty S.,Chen J. K.,Chen J. C.,Loleh S.,Saini N.,.. Quigley R.Androgens augment proximal tubule transport.American Journal of Physiology: Renal Physiology. 2004;287:F452-459
107. Rosano G. M.,Leonardo F.,Pagnotta P.,Pelliccia F.,Panina G.,Cerquetani E.,.. Chierchia S. L.Acute anti-ischemic effect of testosterone in men with coronary artery disease.Circulation. 1999;99:1666-1670
108. Rosano G. M.,Sheiban I.,Massaro R.,Pagnotta P.,Marazzi G.,Vitale C.,.. Fini M.Low testosterone levels are associated with coronary artery disease in male patients with angina.International Journal of Impotence Research. 2007;19:176-182
109. Saltiki K.,Papageorgiou G.,Voidonikola P.,Mantzou E.,Xiromeritis K.,Papamichael C.,.. Stamatelopoulos K.Endogenous estrogen levels are associated with endothelial function in males independently of lipid levels.Endocrine. 2010;37:329-335
110. Savji N.,Rockman C. B.,Skolnick A. H.,Guo Y.,Adelman M. A.,Riles T.,Berger J. S.Association between advanced age and vascular disease in different arterial territories: A population database of over 3.6 million subjects.Journal of the American College of Cardiology. 2013;61:1736-1743
111. Scragg J. L.,Jones R. D.,Channer K. S.,Jones T. H.,Peers C.Testosterone is a potent inhibitor of L-type Ca(2+) channels.Biochemical and Biophysical Research Communications. 2004;318:503-506
112. Sesso H. D.,Lee I. M.,Gaziano J. M.,Rexrode K. M.,Glynn R. J.,Buring J. E.Maternal and paternal history of myocardial infarction and risk of cardiovascular disease in men and women.Circulation. 2001;104:393-398
113. Sewdarsen M.,Jialal I.,Vythilingum S.,Desai R.Sex hormone levels in young Indian patients with myocardial infarction.Arteriosclerosis. 1986;6:418-421
114. Seyrek M.,Yildiz O.,Ulusoy H. B.,Yildirim V.Testosterone relaxes isolated human radial artery by potassium channel opening action.Journal of Pharmacological Sciences. 2007;103:309-316
115. Shahani S.,Braga-Basaria M.,Maggio M.,Basaria S.Androgens and erythropoiesis: Past and present.Journal of Endocrinological Investigation. 2009;32:704-716
116. Shores M. M.,Matsumoto A. M.,Sloan K. L.,Kivlahan D. R.Low serum testosterone and mortality in male veterans.Archives of Internal Medicine. 2006;166:1660-1665
117. Shores M. M.,Smith N. L.,Forsberg C. W.,Anawalt B. D.,Matsumoto A. M.Testosterone treatment and mortality in men with low testosterone levels.Journal of Clinical Endocrinology & Metabolism. 2012;97:2050-2058
118. Sieminska L.,Wojciechowska C.,Swietochowska E.,Marek B.,Kos-Kudla B.,Kajdaniuk D.,Nowalany-Kozielska E.Serum free testosterone in men with coronary artery atherosclerosis.Medical Science Monitor. 2003;9 (5): CR162-CR166
119. Smith A. M.,English K. M.,Malkin C. J.,Jones R. D.,Jones T. H.,Channer K. S.Testosterone does not adversely affect fibrinogen or tissue plasminogen activator (tPA) and plasminogen activator inhibitor-1 (PAI-1) levels in 46 men with chronic stable angina.European Journal of Endocrinology. 2005;152:285-291
120. Smolina K.,Wright F. L.,Rayner M.,Goldacre M. J.(2012). Determinants of the decline in mortality from acute myocardial infarction in England between 2002 and 2010: Linked national database study.British Medical Journal. 344:d8059
121. Soisson V.,Brailly-Tabard S.,Empana J. P.,Feart C.,Ryan J.,Bertrand M.,.. Scarabin P. Y.Low plasma testosterone and elevated carotid intima-media thickness: Importance of low-grade inflammation in elderly men.Atherosclerosis. 2012;223:244-249
122. Storer T. W.,Magliano L.,Woodhouse L.,Lee M. L.,Dzekov C.,Dzekov J.,.. Bhasin S.Testosterone dose-dependently increases maximal voluntary strength and leg power, but does not affect fatigability or specific tension.Journal of Clinical Endocrinology & Metabolism. 2003;88:1478-1485
123. Stout M.,Tew G. A.,Doll H.,Zwierska I.,Woodroofe N.,Channer K. S.,Saxton J. M.Testosterone therapy during exercise rehabilitation in male patients with chronic heart failure who have low testosterone status: A double-blind randomized controlled feasibility study.American Heart Journal. 2012;164:893-901
124. Sullivan M. L.,Martinez C. M.,Gennis P.,Gallagher E. J.The cardiac toxicity of anabolic steroids.Progress in Cardiovascular Diseases. 1998;41:1-15
125. Svartberg J.,Jenssen T.,Sundsfjord J.,Jorde R.The associations of endogenous testosterone and sex hormone-binding globulin with glycosylated hemoglobin levels, in community dwelling men. The Tromso Study.Diabetes & Metabolism. 2004;30:29-34
126. Svartberg J.,von Muhlen D.,Mathiesen E.,Joakimsen O.,Bonaa K. H.,Stensland-Bugge E.Low testosterone levels are associated with carotid atherosclerosis in men.Journal of Internal Medicine. 2006;259:576-582
127. Tan W. S.,Low W. Y.,Ng C. J.,Tan W. K.,Tong S. F.,Ho C.,.. Tan H. M.Efficacy and safety of long-acting intramuscular testosterone undecanoate in aging men: A randomised controlled study.BJU International. 2013;111:1130-1140
128. Thompson P. D.,Ahlberg A. W.,Moyna N. M.,Duncan B.,Ferraro-Borgida M.,White C. M.,.. Heller G. V.Effect of intravenous testosterone on myocardial ischemia in men with coronary artery disease.American Heart Journal. 2002;143:249-256
129. Tivesten A.,Mellstrom D.,Jutberger H.,Fagerberg B.,Lernfelt B.,Orwoll E.,.. Ohlsson C.Low serum testosterone and high serum estradiol associate with lower extremity peripheral arterial disease in elderly men. The MrOS Study in Sweden.Journal of the American College of Cardiology. 2007;50:1070-1076
130. Toma M.,McAlister F. A.,Coglianese E. E.,Vidi V.,Vasaiwala S.,Bakal J. A.,.. Ezekowitz J. A.Testosterone supplementation in heart failure: A meta-analysis.Circulation. Heart Failure. 2012;5:315-321
131. Tsujimura A.,Yamamoto R.,Okuda H.,Yamamoto K.,Fukuhara S.,Yoshioka I.,.. Nonomura N.Low serum free testosterone level is associated with carotid intima-media thickness in middle-aged Japanese men.Endocrine Journal. 2012;59:809-815
132. Tudiver F.,Talbot Y.Why don’t men seek help? Family physicians’ perspectives on help-seeking behavior in men.Journal of Family Practice. 1999;48:47-52
133. Vaidya D.,Dobs A.,Gapstur S. M.,Golden S. H.,Cushman M.,Liu K.,Ouyang P.Association of baseline sex hormone levels with baseline and longitudinal changes in waist-to-hip ratio: Multi-ethnic study of atherosclerosis.International Journal of Obesity. 2012;36:1578-1584
134. van den Beld A. W.,Bots M. L.,Janssen J. A.,Pols H. A.,Lamberts S. W.,Grobbee D. E.Endogenous hormones and carotid atherosclerosis in elderly men.American Journal of Epidemiology. 2003;157:25-31
135. van den Beld A. W.,de Jong F. H.,Grobbee D. E.,Pols H. A.,Lamberts S. W.Measures of bioavailable serum testosterone and estradiol and their relationships with muscle strength, bone density, and body composition in elderly men.Journal of Clinical Endocrinology & Metabolism. 2000;85:3276-3282
136. Vigen R.,O’Donnell C. I.,Baron A. E.,Grunwald G. K.,Maddox T. M.,Bradley S. M.,.. Ho P. M.Association of testosterone therapy with mortality, myocardial infarction, and stroke in men with low testosterone levels.Journal of the American Medical Association. 2013;310:1829-1836
137. Vikan T.,Johnsen S. H.,Schirmer H.,Njolstad I.,Svartberg J.Endogenous testosterone and the prospective association with carotid atherosclerosis in men: The Tromso study.European Journal of Epidemiology. 2009;24:289-295
138. Vlachopoulos C.,Ioakeimidis N.,Terentes-Printzios D.,Aznaouridis K.,Rokkas K.,Aggelis A.,.. Stefanadis C.Plasma total testosterone and incident cardiovascular events in hypertensive patients.American Journal of Hypertension. 2013;26:373-381
139. Webb C. M.,Elkington A. G.,Kraidly M. M.,Keenan N.,Pennell D. J.,Collins P.Effects of oral testosterone treatment on myocardial perfusion and vascular function in men with low plasma testosterone and coronary heart disease.American Journal of Cardiology. 2008;101:618-624
140. Webb C. M.,McNeill J. G.,Hayward C. S.,de Zeigler D.,Collins P.Effects of testosterone on coronary vasomotor regulation in men with coronary heart disease.Circulation. 1999;100:1690-1696
141. Wehr E.,Pilz S.,Boehm B. O.,Marz W.,Grammer T.,Obermayer-Pietsch B.Low free testosterone is associated with heart failure mortality in older men referred for coronary angiography.European Journal of Heart Failure. 2011;13:482-488
142. Wranicz J. K.,Cygankiewicz I.,Rosiak M.,Kula P.,Kula K.,Zareba W.The relationship between sex hormones and lipid profile in men with coronary artery disease.International Journal of Cardiology. 2005;101:105-110
143. Wu H. Y.,Wang X. F.,Wang J. H.,Li J. Y.Testosterone level and mortality in elderly men with systolic chronic heart failure.Asian Journal of Andrology. 2011;13:759-763
144. Yang X. C.,Jing T. Y.,Resnick L. M.,Phillips G. B.Relation of hemostatic risk factors to other risk factors for coronary heart disease and to sex hormones in men.Arteriosclerosis and Thrombosis. 1993;13:467-471
145. Yang X. P.,Reckelhoff J. F.Estrogen, hormonal replacement therapy and cardiovascular disease.Current Opinion in Nephrology and Hypertension. 2011;20:133-138
146. Yeap B. B.,Alfonso H.,Chubb S. A.,Handelsman D. J.,Hankey G. J.,Golledge J.,.. Norman P. E.Lower plasma testosterone or dihydrotestosterone, but not estradiol, is associated with symptoms of intermittent claudication in older men.Clinical Endocrinology. 2013;79 (5): 725-732
147. Yeap B. B.,Hyde Z.,Almeida O. P.,Norman P. E.,Chubb S. A.,Jamrozik K.,.. Hankey G. J.Lower testosterone levels predict incident stroke and transient ischemic attack in older men.Journal of Clinical Endocrinology & Metabolism. 2009;94:2353-2359
148. Yeap B. B.,Hyde Z.,Norman P. E.,Chubb S. A.,Golledge J.Associations of total testosterone, sex hormone-binding globulin, calculated free testosterone, and luteinizing hormone with prevalence of abdominal aortic aneurysm in older men.Journal of Clinical Endocrinology & Metabolism. 2010;95:1123-1130
149. Yildiz O.,Seyrek M.,Gul H.,Un I.,Yildirim V.,Ozal E.,.. Bolu E.Testosterone relaxes human internal mammary artery in vitro.Journal of Cardiovascular Pharmacology. 2005;45:580-585
150. Yue P.,Chatterjee K.,Beale C.,Poole-Wilson P. A.,Collins P.Testosterone relaxes rabbit coronary arteries and aorta.Circulation. 1995;91:1154-1160
151. Yusuf S.,Hawken S.,Ounpuu S.,Dans T.,Avezum A.,Lanas F.,.. Lisheng L.Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): Case-control study.Lancet. 2004;364:937-952
152. Ziaran S.,Goncalves F. M.,Breza J.Patients with prostate cancer treated by ADT have significantly higher fibrinogenemia than healthy control.World Journal of Urology. 2013;31:289-292
153. Zmuda J. M.,Cauley J. A.,Kriska A.,Glynn N. W.,Gutai J. P.,Kuller L. H.Longitudinal relation between endogenous testosterone and cardiovascular disease risk factors in middle-aged men. A 13-year follow-up of former Multiple Risk Factor Intervention Trial participants.American Journal of Epidemiology. 1997;146:609-617